Stay updated on FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma
Sign up to get notified when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.

Latest updates to the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page
- Check2 days agoChange DetectedA site-wide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check9 days agoChange DetectedThe site's footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 403 Forbidden error, showing an access-denied message instead of the study content.SummaryDifference21%

- Check58 days agoChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6, indicating an updated revision of the page content.SummaryDifference0.0%

- Check72 days agoChange DetectedResults for the NCT03453112 study were posted on 2026-08-10, and the page was updated with the Results section and expanded trial details, including rescue medication use, follow-up actions, and treatment timelines; prior results-submission language was superseded by the posted results content.SummaryDifference10%

Stay in the know with updates to FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma
Enter your email address, and we'll notify you when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.